{"id":39947,"date":"2018-12-12T21:31:11","date_gmt":"2018-12-12T20:31:11","guid":{"rendered":"https:\/\/www.fedaiisf.it\/?p=39947"},"modified":"2019-02-08T11:36:45","modified_gmt":"2019-02-08T10:36:45","slug":"comunicato-congiunto-farmindustria-oo-ss-su-governance-farmaceutica-a-rischio-lintero-settore","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/comunicato-congiunto-farmindustria-oo-ss-su-governance-farmaceutica-a-rischio-lintero-settore\/","title":{"rendered":"Joint press release Farmindustria OO.SS. on &quot;Pharmaceutical Governance&quot;: &quot;The whole sector at risk&quot;"},"content":{"rendered":"<h3><a href=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2018\/12\/Comunicato-Farmindustria-OO.SS_.-parte-2.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-39961\" src=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2018\/12\/Comunicato-Farmindustria-OO.SS_.-parte-2.png\" alt=\"\" width=\"993\" height=\"589\" srcset=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2018\/12\/Comunicato-Farmindustria-OO.SS_.-parte-2.png 993w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2018\/12\/Comunicato-Farmindustria-OO.SS_.-parte-2-300x178.png 300w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2018\/12\/Comunicato-Farmindustria-OO.SS_.-parte-2-768x456.png 768w\" sizes=\"auto, (max-width: 993px) 100vw, 993px\" \/><\/a><\/h3>\n<p><a href=\"http:\/\/www.filctemcgil.it\/images\/stories\/flexicontent\/news\/comunicati_stampa\/10_12_12_2018_comunicato_stampa_congiunto_Sindacati_Farmindustria-1.pdf\" target=\"_blank\" rel=\"noopener\">Comunicato Stampa Congiunto<\/a><\/p>\n<hr \/>\n<p>Related news: <a class=\"documento-download\" href=\"http:\/\/www.assogenerici.it\/it\/component\/edocman\/?task=document.viewDoc&amp;id=2187\" target=\"_blank\" rel=\"noopener\">Documento sulla Governance farmaceutica<\/a><\/p>\n<p><a href=\"https:\/\/www.fedaiisf.it\/en\/cricelli-simg-si-alla-revisione-della-governance-farmaceutica-ma-fortemente-orientato-ad-un-controllo-di-tipo-economicistico-e-medici-non-coinvolti-farmindustria-e-assogenerici-concorre\/\" target=\"_blank\" rel=\"noopener\"><strong>Cricelli (SIMG): \u201cYes to the review of pharmaceutical governance, but strongly oriented towards economic control and doctors not involved. Farmindustria and Assogenerici: crushed competition and a return to the past, sorry for the Italians<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/www.apmar.it\/informazioni\/reumatologia\/item\/nuova-governance-del-farmaco-importante-perseguire-il-bene-dei-cittadini-e-non-far-prevalere-logiche-economiche\" target=\"_blank\" rel=\"noopener\">APMAR. Nuova governance del farmaco: importante perseguire il bene dei cittadini e non far prevalere logiche economiche<\/a><\/p>\n<p><a href=\"http:\/\/www.brunoleoni.it\/il-governo-non-rovini-il-settore-farmaceutico\" target=\"_blank\" rel=\"noopener\">IBL. Il governo non rovini il settore farmaceutico<\/a><\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Comunicato Stampa Congiunto Notizie correlate: Documento sulla Governance farmaceutica Cricelli (SIMG): \u201cS\u00ec alla revisione della governance farmaceutica, ma fortemente orientato ad un controllo di tipo economicistico e medici non coinvolti. Farmindustria e Assogenerici: concorrenza schiacciata e ritorno al passato, dispiace per gli italiani APMAR. Nuova governance del farmaco: importante perseguire il bene dei cittadini e &hellip;<\/p>","protected":false},"author":4,"featured_media":39948,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-39947","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-primo-piano"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/39947","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=39947"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/39947\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/39948"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=39947"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=39947"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=39947"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}